Výsledky vyhledávání - "J Christiaan van Denderen"

Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors

Autor: Maria Konsta, Michael T. Nurmohamed, Alexios Iliopoulos, Petros P. Sfikakis, J. Christiaan van Denderen, Ingrid Visman, Grigorios T. Sakelariou, Irene E. van der Horst-Bruinsma

Publikováno v: The Journal of Rheumatology, 50, 342-350
The Journal of rheumatology, 50(3), 342-350. Journal of Rheumatology
Konsta, M, Nurmohamed, M T, Iliopoulos, A, Sfikakis, P P, van Denderen, J C, Visman, I, Sakelariou, G T & van der Horst-Bruinsma, I E 2023, ' Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors ', The Journal of rheumatology, vol. 50, no. 3, pp. 342-350 . https://doi.org/10.3899/jrheum.220061
The Journal of Rheumatology, 50, 3, pp. 342-350

ObjectiveTo examine the prevalence of hip involvement between sexes in patients with ankylosing spondylitis (AS) treated with tumor necrosis factor inhibitors (TNFi) and to estimate the effect of TNFi on radiographic progression of hip involvement co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::963a57f0fbc588617a42a87eef3f2fea
http://www.scopus.com/inward/record.url?scp=85149168509&partnerID=8YFLogxK

Zobrazit plný text záznamu

Fat mass lowers the response to tumor necrosis factor-a blockers in patients with ankylosing spondylitis

Autor: Sebastián E Ibáñez Vodnizza, J Christiaan van Denderen, Irene E van der Horst-Bruinsma, Michael T Nurmohamed, I.M. Visman, Willem F Lems, Francisca Jaime

Publikováno v: Vodnizza, S E I, Nurmohamed, M T, Visman, I M, Christiaan Van Denderen, J, Lems, W F, Jaime, F & Van Der Horst-Bruinsma, I E 2017, ' Fat mass lowers the response to tumor necrosis factor-a blockers in patients with ankylosing spondylitis ', Journal of Rheumatology, vol. 44, no. 9, pp. 1355-1361 . https://doi.org/10.3899/jrheum.170094
Journal of Rheumatology, 44(9), 1355-1361. Journal of Rheumatology

Objective.Our main objective was to assess the relationship between body composition (BC) and response to tumor necrosis factor-α (TNF-α) blocker treatment in patients with ankylosing spondylitis (AS). Our secondary objective was to evaluate the ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc0c8ad7de292b87796a4d0c39d82d5
https://research.vumc.nl/en/publications/b48cd4a8-2e95-454c-8d52-566b7552deb6

Zobrazit plný text záznamu

What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function

Autor: Irene E. van der Horst-Bruinsma, Ben A. C. Dijkmans, Michael T. Nurmohamed, Martijn Steultjens, Salima van Weely, J Christiaan van Denderen, Joost Dekker

Publikováno v: Rheumatology, 52(10):ket240, 1884-1889. Oxford University Press
Van Weely, S F E, Van Denderen, J C, Steultjens, M P M, Nurmohamed, M T, Dijkmans, B A C, Dekker, J & Van der Horst-Bruinsma, I E 2013, ' What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function ', Rheumatology, vol. 52, no. 10, ket240, pp. 1884-1889 . https://doi.org/10.1093/rheumatology/ket240

Objective: A prospective study was conducted in order to establish whether AS patients, who are defined as non-responders after 3 months of anti-TNF therapy, show improvement on performance-based tests of physical functioning. Methods: At baseline an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a724b0600bc015cd7997aa87b4ca27ec
https://doi.org/10.1093/rheumatology/ket240

Zobrazit plný text záznamu

Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study

Autor: Willem F. Lems, Maria A. C. van der Weijden, Ben A. C. Dijkmans, Michael T. Nurmohamed, J Christiaan van Denderen, Irene E. van der Horst-Bruinsma

Publikováno v: van der Weijden, M A C, van denderen, J C, Lems, W F, Nurmohamed, M T, Dijkmans, B A C & van der Horst-Bruinsma, I E 2016, ' Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study ', Journal of Rheumatology, vol. 43, no. 4, pp. 758-764 . https://doi.org/10.3899/jrheum.150857
Journal of Rheumatology, 43(4), 758-764. Journal of Rheumatology

Objective.Ankylosing spondylitis (AS) is characterized by chronic inflammation leading to ankylosis, but also to low bone mineral density (BMD) and vertebral fractures (VFx). Treatment with tumor necrosis factor-α blockers decreases inflammation and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97e4c851f4762b086ddac59a760e5b9c
https://research.vumc.nl/en/publications/fc20243a-0cb5-43fc-bd1d-495b96c20b4b

Zobrazit plný text záznamu

Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography

Autor: Irene E. van der Horst-Bruinsma, J Christiaan van Denderen, Anne S. van Drumpt, Mirjam K. de Vries, Radu A. Manoliu, Barend J. van Royen

Publikováno v: Clinical Rheumatology
Clinical Rheumatology, 29(12), 1433-1438. Springer London
de Vries, M K, van Drumpt, A S, van Royen, B J, van Denderen, J C, Manoliu, R A & van der Horst-Bruinsma, I E 2010, ' Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography ', Clinical Rheumatology, vol. 29, no. 12, pp. 1433-1438 . https://doi.org/10.1007/s10067-010-1480-9

The objective of this study is to investigate the prevalence of Andersson lesions (AL) in ankylosing spondylitis (AS) patients who will start anti-tumor necrosis factor (TNF) treatment. Radiographs and magnetic resonance imaging (MRI) of the spine we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25001d00cc22399db336c4ab8136ef3
https://doi.org/10.1007/s10067-010-1480-9

Zobrazit plný text záznamu

Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis

Autor: P. Jacobs, Ben A. C. Dijkmans, Lilian H D van Tuyl, Rene Westhovens, Tom W J Huizinga, M. L. Westedt, J Christiaan van Denderen, Mart A F J van de Laar, Hans van de Brink, Huub Han, Maarten Boers, S J van der Linden, Willem F. Lems, Robert B Landewé, André Peeters, Alexandre E. Voskuyl

Publikováno v: Annals of the Rheumatic Diseases, 69(5), 807-812
Annals of the Rheumatic Diseases, 69(5), 807-812. BMJ Publishing Group
van Tuyl, H D, Boers, M, Lems, W F, Landewe, R B M, Han, H, ven der Linden, S, van de Laar, M, Westhovens, R, van Denderen, J C, Westedt, ML, Peeters, AJ, Jacobs, P, Huizinga, T W J, Brink, H, Dijkmans, B A C & Voskuyl, A E 2010, ' Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis ', Annals of the Rheumatic Diseases, vol. 69, no. 5, pp. 807-812 . https://doi.org/10.1136/ard.2009.108027
Annals of the rheumatic diseases, 69(5), 807-812. BMJ Publishing Group

Background COBRA (for ‘COmbinatie therapie Bij Rheumatoide Artritis’) combination therapy is effective for the treatment of rheumatoid arthritis (RA), but long-term safety is unknown. This study evaluates survival, comorbidities and joint damage

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1141ab43038a31a667fdbb00ad406d1
https://doi.org/10.1136/ard.2009.108027

Zobrazit plný text záznamu

COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

Autor: Désirée van der Heijde, Ben A. C. Dijkmans, P. Jacobs, André Peeters, Robert Landewé, Sjef van der Linden, Rene Westhovens, J Christiaan van Denderen, A. C. Verhoeven, Mart A F J van de Laar, Marie Louise Westedt, Annelies Boonen, Maarten Boers, H. M. Markusse

Publikováno v: Arthritis & Rheumatism. 46:347-356

Objective The Combinatietherapie Bij Reumatoide Artritis (COBRA) trial demonstrated that step-down combination therapy with prednisolone, methotrexate, and sulfasalazine (SSZ) was superior to SSZ monotherapy for suppressing disease activity and radio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac07c1b0b87e51daa0d9dbf2d9c422c9
https://doi.org/10.1002/art.10083

Zobrazit plný text záznamu

Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis

Autor: Irene E. van der Horst-Bruinsma, J. Christiaan van Denderen, I.M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten

Publikováno v: Journal of Rheumatology, 41(9), 1843-1848. Journal of Rheumatology
van Denderen, J C, Visman, I M, Nurmohamed, M T, Suttorp-Schulten, M S A & van der Horst-Bruinsma, I E 2014, ' Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis ', Journal of Rheumatology, vol. 41, no. 9, pp. 1843-1848 . https://doi.org/10.3899/jrheum.131289

Objective.To investigate whether use of adalimumab decreases the frequency of attacks of anterior uveitis (AU) in patients with ankylosing spondylitis (AS).Methods.Consecutive patients with AS, visiting an outpatient clinic and treated for at least 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05e3c30a2ad130b274aea53be100cd6
https://research.vumc.nl/en/publications/7ca1ba84-a823-4dc2-b59d-ffa0675a44ed

Zobrazit plný text záznamu

Moving instead of asking? performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis

Autor: Ben A. C. Dijkmans, Joost Dekker, Irene E. van der Horst-Bruinsma, Michael T. Nurmohamed, Salima van Weely, J Christiaan van Denderen, Marike van der Leeden, Martijn Steultjens

Publikováno v: Arthritis Research & Therapy, 14(2):R52. BioMed Central
Arthritis Research & Therapy
van Weely, S F E, van Denderen, J C, Steultjens, M P, van der Leeden, M, Nurmohamed, M T, Dekker, J, Dijkmans, B A C & van der Horst-Bruinsma, I E 2012, ' Moving instead of asking? performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis ', Arthritis Research & Therapy, vol. 14, no. 2, R52 . https://doi.org/10.1186/ar3765

Introduction: Ankylosing Spondylitis (AS) is characterised by limitations in physical function. The Bath Ankylosing Spondylitis Functional Index (BASFI) is considered to be the gold-standard to assess physical function in AS patients. However, the BA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3850c82960fe7f9eb587c8d7d02def51
https://research.vumc.nl/en/publications/38c6c759-c39b-4c9b-bd62-43356bfa1061

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání